Clinical trials: Acute Noninfectious Posterior, Intermediate, or Pan Uveitis

Acute Noninfectious Posterior, Intermediate, or Pan Uveitis

Study of FTY720 in Patients With Uveitis

• Withdrawn
• Age: 18 to 60 years
• Phase 2
• Pill or oral medicine

This study will assess the safety, tolerability, and efficacy of FTY720 in patients with acute, noninfectious intermediate, posterior and pan uveitis

Trial name

NCT01791192

Testing

FTY720, Oral Corticosteroid

Sponsor

Novartis Pharmaceuticals